Discover
ACET
Adicet Bio, Inc.
8.12
1 x 6.41
1 x 8.35
bid
ask
+
0.00
0.00%
1 @ 04:00 PM
8.15 +0.03 (0.37%)
| Ytd | -3.56% | |
| 1y | -31.42% |
day range
6.01
52 week range
17.44
| Open | Prev Close | 8.12 | Low | High | Mkt Cap | 75.91M | |||
| Vol | 0.00 | Avg Vol | 93.54K | EPS | -14.90 | P/E | -0.54 | Forward P/E | -0.69 |
| Beta | 1.58 | Short Ratio | 7.04 | Inst. Own | 76.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 8.22 | 200-d Avg | 8.80 | 1yr Est | 6.40 |
| Income Statement | |||
| Operating Expenses | 21.57M | ||
| Research and Development Expense | 17.49M | ||
| Selling, General and Administrative Expense | 4.08M | ||
| Operating Income | -21.57M | ||
| Interest Expense | 23.00K | ||
| Net Income | -20.24M | ||
| Net Income Common Stock | -20.24M | ||
| Net Income Common Stock (USD) | -20.24M | ||
| Consolidated Income | -20.24M | ||
| Earnings per Basic Share | -1.88 | ||
| Earnings per Basic Share (USD) | -1.88 | ||
| Earnings per Diluted Share | -1.88 | ||
| Earning Before Interest & Taxes (EBIT) | -20.22M | ||
| Earning Before Interest & Taxes (USD) | -20.22M | ||
| Weighted Average Shares | 10.74M | ||
| Weighted Average Shares Diluted | 10.74M | ||
| Balance Sheet | |||
| Cash and Equivalents | 39.11M | ||
| Cash and Equivalents (USD) | 39.11M | ||
| Investments | 101.35M | ||
| Investments Current | 101.35M | ||
| Current Assets | 140.07M | ||
| Property, Plant & Equipment Net | 26.36M | ||
| Total Assets | 169.38M | ||
| Debt Current | 2.88M | ||
| Total Debt | 13.90M | ||
| Current Liabilities | 18.30M | ||
| Debt Non-Current | 11.02M | ||
| Total Liabilities | 29.32M | ||
| Accumulated Retained Earnings (Deficit) | -634.94M | ||
| Accumulated Other Comprehensive Income | -37.00K | ||
| Shareholders Equity | 140.07M | ||
| Shareholders Equity (USD) | 140.07M | ||
| Assets Non-Current | 29.31M | ||
| Total Debt (USD) | 13.90M | ||
| Liabilities Non-Current | 11.02M | ||
| Trade and Non-Trade Payables | 2.93M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.09M | ||
| Net Cash Flow from Financing | -65.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.68M | ||
| Capital Expenditure | -37.00K | ||
| Net Cash Flow from Investing | 18.88M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 18.92M | ||
| Net Cash Flow from Operations | -21.49M | ||
| Share Based Compensation | 1.30M | ||